Cargando…

Use of prothrombin complex concentrate in warfarin anticoagulation reversal in the emergency department: a quality improvement study of administration delays

BACKGROUND: Quick reversal of warfarin anticoagulation is important in life threatening bleeding. The aim of this study is to improve the administration delay when using Prothrombin Complex Concentrate (PCC) for the emergent reversal of warfarin anticoagulation in the emergency department. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Bordeleau, Simon, Poitras, Julien, Marceau, Danièle, Breton, Carolle, Beaupré, Pierre, Archambault, Patrick M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365812/
https://www.ncbi.nlm.nih.gov/pubmed/25880097
http://dx.doi.org/10.1186/s12913-015-0775-6
_version_ 1782362284426788864
author Bordeleau, Simon
Poitras, Julien
Marceau, Danièle
Breton, Carolle
Beaupré, Pierre
Archambault, Patrick M
author_facet Bordeleau, Simon
Poitras, Julien
Marceau, Danièle
Breton, Carolle
Beaupré, Pierre
Archambault, Patrick M
author_sort Bordeleau, Simon
collection PubMed
description BACKGROUND: Quick reversal of warfarin anticoagulation is important in life threatening bleeding. The aim of this study is to improve the administration delay when using Prothrombin Complex Concentrate (PCC) for the emergent reversal of warfarin anticoagulation in the emergency department. METHODS: An audit and feedback quality improvement project was conducted in three phases: a retrospective audit phase, an analysis and feedback phase and prospective evaluation phase. The charts of all eligible patients in a single Emergency Department (ED) in Québec, Canada, who received PCC since the introduction of this product in 2009 until October 31, 2011, were retrospectively audited. The administration delay of PCC was calculated from the time of prescription to the time of administration. With the data, we determined where improvements could be attained, and jointly with all stakeholders in the ED and the blood bank, we created an action plan to ensure the timely administration of PCC. The action plan was then implemented and a six-month prospective evaluation study was conducted to determine any improvement. RESULTS: Seventy-seven charts were reviewed in the retrospective chart audit. The mean administration delay was 73.6 minutes (STD [34.1]) with a median of 70.0 minutes (25–75% IQR [45.0–95.0]). We found that this delay was principally due to the following barriers: communication problems between the ED and the blood bank as well as delivery inefficiencies. An action plan that involved a flowchart to remind all clinicians how to order PCC and a new delivery method from the blood bank to the ED were developed. During the 6 months following the implementation of our action plan, 39 patients received PCC and the mean administration time decreased to 33.2 minutes (STD [14.2])(p < .0001) with a median of 30.0 minutes (25–75% IQR [24.3–38.8]). CONCLUSION: By implementing an action plan comprising of a flowchart and a new delivery process, this audit and feedback quality improvement project reduced the administration time of PCC by more than half. Future studies to measure the impact of a similar audit and feedback process involving an action plan in other centers should be conducted before this type of quality improvement process is implemented on wider scale.
format Online
Article
Text
id pubmed-4365812
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43658122015-03-20 Use of prothrombin complex concentrate in warfarin anticoagulation reversal in the emergency department: a quality improvement study of administration delays Bordeleau, Simon Poitras, Julien Marceau, Danièle Breton, Carolle Beaupré, Pierre Archambault, Patrick M BMC Health Serv Res Research Article BACKGROUND: Quick reversal of warfarin anticoagulation is important in life threatening bleeding. The aim of this study is to improve the administration delay when using Prothrombin Complex Concentrate (PCC) for the emergent reversal of warfarin anticoagulation in the emergency department. METHODS: An audit and feedback quality improvement project was conducted in three phases: a retrospective audit phase, an analysis and feedback phase and prospective evaluation phase. The charts of all eligible patients in a single Emergency Department (ED) in Québec, Canada, who received PCC since the introduction of this product in 2009 until October 31, 2011, were retrospectively audited. The administration delay of PCC was calculated from the time of prescription to the time of administration. With the data, we determined where improvements could be attained, and jointly with all stakeholders in the ED and the blood bank, we created an action plan to ensure the timely administration of PCC. The action plan was then implemented and a six-month prospective evaluation study was conducted to determine any improvement. RESULTS: Seventy-seven charts were reviewed in the retrospective chart audit. The mean administration delay was 73.6 minutes (STD [34.1]) with a median of 70.0 minutes (25–75% IQR [45.0–95.0]). We found that this delay was principally due to the following barriers: communication problems between the ED and the blood bank as well as delivery inefficiencies. An action plan that involved a flowchart to remind all clinicians how to order PCC and a new delivery method from the blood bank to the ED were developed. During the 6 months following the implementation of our action plan, 39 patients received PCC and the mean administration time decreased to 33.2 minutes (STD [14.2])(p < .0001) with a median of 30.0 minutes (25–75% IQR [24.3–38.8]). CONCLUSION: By implementing an action plan comprising of a flowchart and a new delivery process, this audit and feedback quality improvement project reduced the administration time of PCC by more than half. Future studies to measure the impact of a similar audit and feedback process involving an action plan in other centers should be conducted before this type of quality improvement process is implemented on wider scale. BioMed Central 2015-03-15 /pmc/articles/PMC4365812/ /pubmed/25880097 http://dx.doi.org/10.1186/s12913-015-0775-6 Text en © Bordeleau et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Bordeleau, Simon
Poitras, Julien
Marceau, Danièle
Breton, Carolle
Beaupré, Pierre
Archambault, Patrick M
Use of prothrombin complex concentrate in warfarin anticoagulation reversal in the emergency department: a quality improvement study of administration delays
title Use of prothrombin complex concentrate in warfarin anticoagulation reversal in the emergency department: a quality improvement study of administration delays
title_full Use of prothrombin complex concentrate in warfarin anticoagulation reversal in the emergency department: a quality improvement study of administration delays
title_fullStr Use of prothrombin complex concentrate in warfarin anticoagulation reversal in the emergency department: a quality improvement study of administration delays
title_full_unstemmed Use of prothrombin complex concentrate in warfarin anticoagulation reversal in the emergency department: a quality improvement study of administration delays
title_short Use of prothrombin complex concentrate in warfarin anticoagulation reversal in the emergency department: a quality improvement study of administration delays
title_sort use of prothrombin complex concentrate in warfarin anticoagulation reversal in the emergency department: a quality improvement study of administration delays
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365812/
https://www.ncbi.nlm.nih.gov/pubmed/25880097
http://dx.doi.org/10.1186/s12913-015-0775-6
work_keys_str_mv AT bordeleausimon useofprothrombincomplexconcentrateinwarfarinanticoagulationreversalintheemergencydepartmentaqualityimprovementstudyofadministrationdelays
AT poitrasjulien useofprothrombincomplexconcentrateinwarfarinanticoagulationreversalintheemergencydepartmentaqualityimprovementstudyofadministrationdelays
AT marceaudaniele useofprothrombincomplexconcentrateinwarfarinanticoagulationreversalintheemergencydepartmentaqualityimprovementstudyofadministrationdelays
AT bretoncarolle useofprothrombincomplexconcentrateinwarfarinanticoagulationreversalintheemergencydepartmentaqualityimprovementstudyofadministrationdelays
AT beauprepierre useofprothrombincomplexconcentrateinwarfarinanticoagulationreversalintheemergencydepartmentaqualityimprovementstudyofadministrationdelays
AT archambaultpatrickm useofprothrombincomplexconcentrateinwarfarinanticoagulationreversalintheemergencydepartmentaqualityimprovementstudyofadministrationdelays